ARTICLE | Company News
Fresenius SE, Octapharma deal
November 9, 2009 8:00 AM UTC
Fresenius' Fresenius Kabi AG subsidiary granted Octapharma an exclusive license to use HESylation technology to develop a recombinant protein for an undisclosed indication. The technology couples hydr...